Trademark: 90746118
Status Date
Thursday, March 21, 2024
Filing Date
Tuesday, June 1, 2021
Published for Opposition
Tuesday, September 20, 2022
5 pharmaceutical preparations for kinase inhibition, namely kinase inhibitors for preventing drug resistance and targeting non-cancer diseases; biochemicals, namely, kinases substrates and inhibitors for the treatment of oncology and autoimmune disorders
1 biochemicals, namely, kinases substrates and inhibitors for clinical and medical laboratory use
44 providing medical information in the field of therapeutics for treating oncology and autoimmune disorders; consulting in the field of therapeutics for treating oncology and autoimmune disorders
42 research and development services in the field of drug discovery and diagnostics; research and development services in the field of kinase inhibitors; research and development of enzyme inhibitors, namely, kinases; research and development services in the field of drug discovery and diagnostics using machine learning and AI; providing medical research information in the fields of drug discovery and therapeutics for treating oncology and autoimmune disorders; consulting in the fields of drug discovery and development of therapeutics for treating oncology and autoimmune disorders
Mar 22, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 21, 2024
Sou Extension 3 Granted
Mar 21, 2024
Sou Extension 3 Filed
Mar 21, 2024
Sou Teas Extension Received
Nov 10, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 8, 2023
Sou Extension 2 Granted
Nov 8, 2023
Sou Extension 2 Filed
Nov 8, 2023
Sou Teas Extension Received
May 12, 2023
Notice Of Approval Of Extension Request E-Mailed
May 10, 2023
Sou Extension 1 Granted
May 10, 2023
Sou Extension 1 Filed
May 10, 2023
Sou Teas Extension Received
Nov 15, 2022
Noa E-Mailed - Sou Required From Applicant
Sep 20, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 20, 2022
Published For Opposition
Aug 31, 2022
Notification Of Notice Of Publication E-Mailed
Aug 12, 2022
Approved For Pub - Principal Register
Aug 12, 2022
Examiner's Amendment Entered
Aug 12, 2022
Notification Of Examiners Amendment E-Mailed
Aug 12, 2022
Examiners Amendment E-Mailed
Aug 12, 2022
Examiners Amendment -Written
Aug 9, 2022
Teas/Email Correspondence Entered
Aug 8, 2022
Correspondence Received In Law Office
Aug 8, 2022
Teas Response To Office Action Received
Feb 16, 2022
Notification Of Non-Final Action E-Mailed
Feb 16, 2022
Non-Final Action E-Mailed
Feb 16, 2022
Non-Final Action Written
Feb 15, 2022
Assigned To Examiner
Aug 24, 2021
New Application Office Supplied Data Entered
Jun 4, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
